Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hypercalcemia disease that occurs between 28 days to one year of life.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
2 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and procedural interventions. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for hypercalcemia, infantile. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (20%), and Clinical Trial Publication (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 |
Data assembled from 4 of 12 sources · Last updated Oct 3, 2026, 2:01 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 2 | 20% |
Clinical study results | 1 | 10% |
Disease patterns and progression | 1 | 10% |
Eltan M (2026). [PMID: 41327588](https://pubmed.ncbi.nlm.nih.gov/41327588/). *Clinical endocrinology*. [Clinical Trial Publication]
Ahel IB (2026). [PMID: 41982776](https://pubmed.ncbi.nlm.nih.gov/41982776/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Amato LA (2025). [PMID: 40384348](https://pubmed.ncbi.nlm.nih.gov/40384348/). *Clinical endocrinology*. [Epidemiology / Natural History]
Kulikova KS (2025). [PMID: 41640145](https://pubmed.ncbi.nlm.nih.gov/41640145/). *Problemy endokrinologii*. [Case Report / Case Series]
Park E (2025). [PMID: 40627324](https://pubmed.ncbi.nlm.nih.gov/40627324/). *CEN Case Rep*. [Case Report / Case Series]
Mura-Escorche G (2025). [PMID: 40943461](https://pubmed.ncbi.nlm.nih.gov/40943461/). *International journal of molecular sciences*. [Case Report / Case Series]
Brancatella A (2024). [PMID: 38329607](https://pubmed.ncbi.nlm.nih.gov/38329607/). *Journal of endocrinological investigation*. [Review / Meta-Analysis]
Jones G (2024). [PMID: 38780860](https://pubmed.ncbi.nlm.nih.gov/38780860/). *Journal of endocrinological investigation*. [Review / Meta-Analysis]
Salama M (2024). [PMID: 38414167](https://pubmed.ncbi.nlm.nih.gov/38414167/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Verjans M (2024). [PMID: 38753084](https://pubmed.ncbi.nlm.nih.gov/38753084/). *Pediatric nephrology (Berlin, Germany)*. [Case Report / Case Series]
AI-curated news mentioning hypercalcemia, infantile
Updated Feb 20, 2026
A recent case report highlights sinus bradycardia as an atypical manifestation of severe hypercalcemia. This finding adds to the understanding of hypercalcemia's clinical presentations and may influence future diagnostic approaches.